ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

Abd El-Baky, Nawal; Amara, Amro A.; Redwan, Elrashdy M.*
Vaccines2023-3DOI: 10.3390/vaccines11030548
3被引4阅读
引用收藏
分享

摘要

The adaptive (T-cell-mediated) immune response is a key player in determining the clinical outcome, in addition to neutralizing antibodies, after SARS-CoV-2 infection, as well as supporting the efficacy of vaccines. T cells recognize viral-derived peptides bound to major histocompatibility complexes (MHCs) so that they initiate cell-mediated immunity against SARS-CoV-2 infection or can support developing a high-affinity antibody response. SARS-CoV-2-derived peptides bound to MHCs are characterized via bioinformatics or mass spectrometry on the whole proteome scale, named immunopeptidomics. They can identify potential vaccine targets or therapeutic approaches for SARS-CoV-2 or else may reveal the heterogeneity of clinical outcomes. SARS-CoV-2 epitopes that are naturally processed and presented on the human leukocyte antigen class I (HLA-I) and class II (HLA-II) were identified for immunopeptidomics. Most of the identified SARS-CoV-2 epitopes were canonical and out-of-frame peptides derived from spike and nucleocapsid proteins, followed by membrane proteins, whereby many of which are not caught by existing vaccines and could elicit effective responses of T cells in vivo. This review addresses the detection of SARS-CoV-2 viral epitopes on HLA-I and HLA-II using bioinformatics prediction and mass spectrometry (HLA peptidomics). Profiling the HLA-I and HLA-II peptidomes of SARS-CoV-2 is also detailed.

学科与关键词

关键词
HLA-IHLA-IISARS-CoV-2immunopeptidomicsMHCsT-cell-mediated immunity
相关
加载中…
  • Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
    Chakraborty, Chiranjib; Sharma, Ashish Ranjan; Bhattacharya, Manoji; Sharma, Garima; Lee, Sang-Soo*Archives of Medical Research, 2021, 52(4): 362-370.被引 26
  • Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins
    Deng, Jieping; Pan, Junping; Qiu, Minghui; Mao, Lipeng; Wang, Zhigang; Zhu, Guodong; Gao, Lijuan; Su, Jun; Hu, Yutian; Luo, Oscar Junhong; Chen, Guobing*; Wang, Pengcheng*Journal of Leukocyte Biology, 2021, 110(6): 1171-1180.被引 9
  • CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
    Qiu, Congling; Xiao, Chanchan; Wang, Zhigang; Zhu, Guodong; Mao, Lipeng; Chen, Xiongfei; Gao, Lijuan; Deng, Jieping; Su, Jun; Su, Huanxing; Fang, Evandro Fei; Zhang, Zhang-Jin; Zhang, Jikai; Xie, Caojun; Yuan, Jun; Luo, Oscar Junhong; Huang, Lian; Wang, Pengcheng*; Chen, Guobing*Frontiers in Immunology, 2022, 12: 764949.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Vaccines
发表日期
2023-03
卷期
第 11 卷, 第 3 期
页码
548
DOI
10.3390/vaccines11030548
成果收录
SCIE

作者

  • A

    Abd El-Baky, Nawal (第一作者)

  • A

    Amara, Amro A.

查看全部 3 位作者收起作者
  • R

    Redwan, Elrashdy M. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417